Inflammatory factors linked to inhibition of factor VIII gene therapy in hemophilia A

As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from the transferred FVIII gene. …read more

Source: EurekAlert

(Visited 3 times, 1 visits today)

Popular Posts